✦ LIBER ✦

Meta-analysis of Toxicities in Phase I or II Trials Studying the Use of Target Therapy (TT) Combined With Radiation Therapy in Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)

✍ Scribed by Santos, M.; Lefeuvre, D.; Le Teuff, G.; Bourgier, C.; Le Pechoux, C.; Soria, J.; Pignon, J.; Deutsch, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II study of Docetaxel (Taxoter

✍ Aamdal, S; Lauvvang, G; Owre, K; Hatlevoll, R; Armellini, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Phase II Study of Nimotuzumab in Combina

✍ Nishimura, Y.; Harada, H.; Soejima, T.; Tsujino, K.; Hayakawa, K.; Kozuka, T.; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

A phase I/II study of antibody targeted

✍ Lorigan, P; Carmichael, J; Woll, P.J; O'Byrne, K; Browne, S; Sopwith, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Phase II study of sunitinib as maintenan

✍ Gervais, Radj; Hainsworth, John D.; Blais, Normand; Besse, Benjamin; Laskin, Jan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Phase I/II study of combined chemoradiat

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 165 KB

1084 Interim results of a phase II trial

✍ Zalcberg, J.R.; Bishop, J.F.; Millward, M.J.; Zimet, A.; Laird, J.; Barter, C.; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB